Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBeijing Chao Yang Hospital

About this trial

To verify whether the transpulmonary pressure-guided mechanical ventilation strategy can reduce right ventricular involvement, especially the incidence of acute cor pulmonale (ACP), in patients with moderate to severe ARDS induced by pneumonia compared with the currently widely used right ventricular protective mechanical ventilation strategy.

Eligibility criteria

Qualifiers

Age ≥ 18 years old

ARDS caused by pneumonia (New Global Definition of ARDS)

PaO2/FiO2≤200mmHg

Received invasive mechanical ventilation

Disqualifiers

Invasive mechanical ventilation duration > 48 hours

History of pulmonary hypertension caused by various reasons

Severe arrhythmia

BMI>30kg/m2

Trial design

Treatments tested in this trial

  • Transpulmonary pressure guided mechanical ventilation strategy

Treatment groups

180 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators